Pathway-Centric Integrative Analysis Identifies RRM2 as a Prognostic Marker in Breast Cancer Associated with Poor Survival and Tamoxifen ResistanceNagireddy Putluri, Arun Sreekumar, Vasanta Putluri et al.|Neoplasia|2014Cited by 90